ARTICLE | Clinical News
Nplate romiplostim regulatory update
January 11, 2010 8:00 AM UTC
The U.K.'s NICE delayed an appraisal meeting set for Jan. 7 to discuss Amgen's Nplate romiplostim to treat chronic idiopathic thrombocytopenic purpura (ITP). According to NICE, the company is submitti...